drugset / Trial / NCT04377243
Immunotherapy of Chronic Kidney Failure
RandomizedParallel-groupDouble-blindTreatment
Summary
Kidney failure can result from inflammatory renal disease in the context of autoimmunity because the kidney is targeted by host's immune response against self. There are many causes to this, but abnormal kidney function tests, i.e., BUN and creatinine, can reveal the disease. Oral delivery of kidney cells is ought to produce the immune tolerance - phenomenon is known as oral tolerance. Preliminary studies produced convincing evidence that this hypothesis holds true and has not produced any adverse side effects. Intended open label Phase II aims to confirm these findings.
Timeline
- Start
- 2020-06-16
- Primary completion
- 2021-05-15
- Completion
- 2021-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | V8 | Unknown | 850 mg | Oral |